| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.28 | 8e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |